CollPlant Biotechnologies Ltd.
CLGN
Rank in Stocks
#29362
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine... CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics. All of CollPlant's offerings are underpinned by its proprietary plant-based genetic engineering technology, which facilitates the production of recombinant type I human collagen. Its diverse product portfolio encompasses BioInks engineered for 3D tissue and organ fabrication; dermal and soft tissue fillers designed to diminish wrinkles; and innovative breast implants, both 3D bioprinted and injectable, aimed at promoting breast tissue regeneration. CollPlant also provides a 3D bioprinted regenerative soft tissue matrix. Specialized products include VergenixSTR, a soft tissue repair matrix targeting tendinopathy, and VergenixFG, an advanced wound care treatment for deep surgical incisions and persistent wounds such as diabetic, venous, and pressure ulcers, burns, and bedsores. The company maintains strategic collaboration agreements with numerous partners, including 3D Systems Corporation, CellInk (a BICO Group company), the Advanced Regenerative Manufacturing Institute, the RegenMed Development Organization, Israel's Technion Institute of Technology, AbbVie, and STEMCELL. Established in Rehovot, Israel, in 2004, the company was formerly known as CollPlant Holdings Ltd. before adopting its current name in June 2019.
Share Price
$4.29
Last synced: 2026-11-09
Market Cap
$8.11M
Change (1 day)
8.06%
Change (1 year)
126.98%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CollPlant Biotechnologies Ltd. (CLGN)
Category
Healthcare
Operating Margin for CollPlant Biotechnologies Ltd. (CLGN)
Operating Margin as of November 2026 TTM: -3,900.94%
According to CollPlant Biotechnologies Ltd.'s latest financial reports, its current operating margin (TTM) is -3,900.94%. At the end of 2025 the company had an operating margin of -484.31%.
Operating Margin history for CollPlant Biotechnologies Ltd. from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -3,900.94% | 705.46% |
| 2025 | -484.31% | -85.54% |
| 2024 | -3,349.71% | 4,786.52% |
| 2023 | -68.55% | -98.80% |
| 2022 | -5,718.06% | -1,361,542.86% |
| 2021 | 0.42% | -100.46% |
| 2020 | -91.23% | -72.29% |
| 2019 | -329.21% | 287.72% |
| 2018 | -84.91% | -93.18% |
| 2017 | -1,244.19% | -86.81% |
| 2016 | -9,433.24% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.01% |
US
|
|
| -149.01% | -99.96% |
US
|
|
| 25.57% | -100.01% |
AU
|
|
| 31.23% | -100.01% |
BE
|
|
| 29.35% | -100.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about CollPlant Biotechnologies Ltd.'s operating margin
What is CollPlant Biotechnologies Ltd.'s operating margin?
CollPlant Biotechnologies Ltd.'s operating margin is -3,900.94%, as of Nov 2026.
What was CollPlant Biotechnologies Ltd.'s operating margin in 2025?
In 2025, CollPlant Biotechnologies Ltd.'s operating margin was -484.31%, compared with -3,349.71% in 2024.
How has CollPlant Biotechnologies Ltd.'s operating margin changed since 2020?
From 2020 to 2025, CollPlant Biotechnologies Ltd.'s operating margin was highest in 2021 (0.42%) and lowest in 2022 (-5,718.06%).
How does CollPlant Biotechnologies Ltd.'s operating margin compare with similar companies?
CollPlant Biotechnologies Ltd.'s operating margin (-3,900.94%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.